A 28-year-old woman from Himachal Pradesh presents with a 7-day history of fever, severe headache, myalgia, and rash on the wrists and ankles. On examination, petechial rash is noted on the flexor surfaces. She has no eschar. Platelet count is 92,000/μL, and serum creatinine is 1.8 mg/dL. Blood cultures are pending. She reports tick exposure while hiking 10 days ago. What is the most appropriate next step?

Explanation

## Clinical Diagnosis: Rocky Mountain Spotted Fever (RMSF) The clinical presentation strongly suggests RMSF: - **Petechial rash** on flexor surfaces (wrists, ankles) — classic distribution - **Fever, headache, myalgia** — constitutional triad - **Tick exposure** 10 days prior — appropriate incubation period (5–14 days) - **Thrombocytopenia and acute kidney injury** — indicators of severe disease - **Absence of eschar** — eschar is rare in RMSF (seen in scrub typhus and African tick-bite fever) - **Geographic risk** (Himachal Pradesh) — RMSF endemic in northern India ## Management Algorithm ```mermaid flowchart TD A[Suspected rickettsial disease<br/>+ petechial rash + tick exposure]:::outcome --> B{Clinical diagnosis<br/>likely?}:::decision B -->|Yes| C[Start doxycycline<br/>100 mg BD immediately]:::action B -->|No| D[Await confirmatory tests] C --> E[Defervescence in 24-48 hrs]:::outcome E --> F[Continue 5-7 days]:::action D --> G[Risk of complications<br/>increases]:::urgent ``` ## Rationale for Immediate Therapy **Key Point:** RMSF is a medical emergency. Mortality increases dramatically with delayed treatment, reaching 20–30% if therapy is delayed beyond day 5 of illness. This patient is already on day 7 and showing signs of organ dysfunction. **High-Yield:** Doxycycline is the ONLY effective first-line agent for RMSF. It must be started empirically on clinical grounds — serologic confirmation takes 5–7 days and is not suitable for acute management. **Mnemonic: RMSF-STAT** — Rickettsial disease, Mortality high if delayed, Start doxycycline, Stat (immediately), Avoid delays, Tick exposure history ## Why NOT the Other Options? | Step | Reason | |------|--------| | **Await serology** | Serologic tests (IFA, ELISA) require 5–7 days; patient is already on day 7 with organ dysfunction. Delay increases mortality risk. | | **IVIG for vasculitis** | RMSF is a rickettsial infection, not primary vasculitis. IVIG is not indicated and delays appropriate therapy. | | **Lumbar puncture first** | While meningitis must be considered, RMSF can cause meningitis and requires doxycycline regardless. LP is not a prerequisite; doxycycline penetrates CSF adequately. | ## Dosing in Severe Disease **Clinical Pearl:** In severe RMSF (as evidenced by AKI, thrombocytopenia, and petechial rash), some experts recommend: - Doxycycline 100 mg IV/PO BD (standard) - Continue until defervescence + 3 additional days - Monitor renal function; adjust if creatinine >3 mg/dL - Supportive care for acute kidney injury (fluid management, monitoring) ## Expected Response Defervescence typically occurs within 24–48 hours of starting doxycycline. Failure to defervesce should prompt consideration of: - Misdiagnosis (consider other causes of petechial rash) - Complications (DIC, ARDS, septic shock) - Drug resistance (rare with doxycycline)